TCR Bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD4+ T cells during viral infection

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3618-3630

  Yousef, Sara ^a   Planas, Raquel ^a,b   Chakroun, Karima ^a   Hoffmeister Ullerich, Sabine ^a   Binder, Thomas M C ^a   Eiermann, Thomas H ^a   Martin, Roland ^a,b   Sospedra, Mireia ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTERLEUKIN 4; PROTEIN VP1; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; JC VIRUS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; HLA-D ANTIGENS; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 84866564112     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201612     Document Type: Article

References (63)

1. Janssen, E. M., E. E. Lemmens, T. Wolfe, U. Christen, M. G. von Herrath, and S. P. Schoenberger. 2003. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421: 852-856. (Pubitemid 36254145)
2. Kaech, S. M., and R. Ahmed. 2003. Immunology. CD8 T cells remember with a little help. Science 300: 263-265. (Pubitemid 36433703)
3. Matloubian, M., R. J. Concepcion, and R. Ahmed. 1994. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68: 8056-8063. (Pubitemid 24362694)
4. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339. (Pubitemid 36433726)
5. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342. (Pubitemid 36433727)
6. von Herrath, M. G., M. Yokoyama, J. Dockter, M. B. Oldstone, and J. L. Whitton. 1996. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 70: 1072-1079. (Pubitemid 26029026)
7. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662. (Pubitemid 37310924)
8. Planz, O., S. Ehl, E. Furrer, E. Horvath, M. A. Bründler, H. Hengartner, and R. M. Zinkernagel. 1997. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94: 6874-6879.
9. McNeil, A. C., W. L. Shupert, C. A. Iyasere, C. W. Hallahan, J. A. Mican, R. T. Davey, Jr., and M. Connors. 2001. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc. Natl. Acad. Sci. USA 98: 13878-13883. (Pubitemid 33115992)
10. Rosenberg, E. S., M. Altfeld, S. H. Poon, M. N. Phillips, B. M. Wilkes, R. L. Eldridge, G. K. Robbins, R. T. D'Aquila, P. J. Goulder, and B. D. Walker. 2000. Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
11. Day, C. L., G. M. Lauer, G. K. Robbins, B. McGovern, A. G. Wurcel, R. T. Gandhi, R. T. Chung, and B. D. Walker. 2002. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J. Virol. 76: 12584-12595. (Pubitemid 35386944)
12. Gasnault, J., M. Kahraman, M. G. de Goër de Herve, D. Durali, J. F. Delfraissy, and Y. Taoufik. 2003. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 17: 1443-1449. (Pubitemid 36900544)
13. Major, E. O. 2010. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu. Rev. Med. 61: 35-47.
14. Gheuens, S., G. Pierone, P. Peeters, and I. J. Koralnik. 2010. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J. Neurol. Neurosurg. Psychiatry 81: 247-254.
15. Puri, V., N. Chaudhry, P. Gulati, N. Patel, M. Tatke, and S. Sinha. 2010. Progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+T lymphocytopenia. Neurol. India 58: 118-121.
16. Tan, C. S., and I. J. Koralnik. 2010. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 9: 425-437.
17. Padgett, B. L., D. L. Walker, G. M. ZuRhein, R. J. Eckroade, and B. H. Dessel. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1: 1257-1260.
18. Koralnik, I. J., R. A. Du Pasquier, M. J. Kuroda, J. E. Schmitz, X. Dang, Y. Zheng, M. Lifton, and N. L. Letvin. 2002. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J. Immunol. 168: 499-504. (Pubitemid 34014154)
19. Du Pasquier, R. A., M. J. Kuroda, Y. Zheng, J. Jean-Jacques, N. L. Letvin, and I. J. Koralnik. 2004. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127: 1970-1978. (Pubitemid 39150256)
20. Du Pasquier, R. A., M. C. Stein, M. A. Lima, X. Dang, J. Jean-Jacques, Y. Zheng, N. L. Letvin, and I. J. Koralnik. 2006. JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients. J. Neuroimmunol. 176: 181-186. (Pubitemid 44080337)
21. Gheuens, S., E. Bord, S. Kesari, D. M. Simpson, R. T. Gandhi, D. B. Clifford, J. R. Berger, L. Ngo, and I. J. Koralnik. 2011. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J. Virol. 85: 7256-7263.
22. Gorelik, L., M. Lerner, S. Bixler, M. Crossman, B. Schlain, K. Simon, A. Pace, A. Cheung, L. L. Chen, M. Berman, et al. 2010. Anti-JC virus antibodies: implications for PML risk stratification. Ann. Neurol. 68: 295-303.
23. Koralnik, I. J. 2002. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J. Neurovirol. 8(Suppl 2): 59-65. (Pubitemid 36097778)
24. Gillespie, S. M., Y. Chang, G. Lemp, R. Arthur, S. Buchbinder, A. Steimle, J. Baumgartner, T. Rando, D. Neal, G. Rutherford, et al. 1991. Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989. Ann. Neurol. 30: 597-604.
25. Stoner, G. L., C. F. Ryschkewitsch, D. L. Walker, and H. D. Webster. 1986. JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy. Proc. Natl. Acad. Sci. USA 83: 2271-2275.
26. Zonios, D. I., J. Falloon, J. E. Bennett, P. A. Shaw, D. Chaitt, M. W. Baseler, J. W. Adelsberger, J. A. Metcalf, M. A. Polis, S. J. Kovacs, et al. 2008. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 112: 287-294.
27. Kleinschmidt-DeMasters, B. K., and K. L. Tyler. 2005. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 353: 369-374. (Pubitemid 41132341)
28. Langer-Gould, A., S. W. Atlas, A. J. Green, A. W. Bollen, and D. Pelletier. 2005. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353: 375-381. (Pubitemid 41132342)
29. Jilek, S., E. Jaquiéry, H. H. Hirsch, A. Lysandropoulos, M. Canales, L. Guignard, M. Schluep, G. Pantaleo, and R. A. Du Pasquier. 2010. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a crosssectional and longitudinal study. Lancet Neurol. 9: 264-272.
30. Urbach, H. 2010. Comment to: progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis: C. D. Tan, I. J. Koralnik Lancet Neurol. 2010;9:425-37.
31. Clin. Neuroradiol. 20: 141-142.
32. del Pilar Martin, M., P. D. Cravens, R. Winger, E. M. Frohman, M. K. Racke, T. N. Eagar, S. S. Zamvil, M. S. Weber, B. Hemmer, N. J. Karandikar, et al. 2008. Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch. Neurol. 65: 1596-1603.
33. Stüve, O., C. M. Marra, K. R. Jerome, L. Cook, P. D. Cravens, S. Cepok, E. M. Frohman, J. T. Phillips, G. Arendt, B. Hemmer, et al. 2006. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 59: 743-747. (Pubitemid 43673151)
34. Yednock, T. A., C. Cannon, L. C. Fritz, F. Sanchez-Madrid, L. Steinman, and N. Karin. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356: 63-66.
35. Koralnik, I. J. 2006. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann. Neurol. 60: 162-173. (Pubitemid 44182391)
36. Tan, K., R. Roda, L. Ostrow, J. McArthur, and A. Nath. 2009. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72: 1458-1464.
37. Aly, L., S. Yousef, S. Schippling, I. Jelcic, P. Breiden, J. Matschke, R. Schulz, S. Bofill-Mas, L. Jones, V. Demina, et al. 2011. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy- immune reconstitution inflammatory syndrome. Brain 134: 2687-2702.
38. Turner, S. J., P. C. Doherty, J. McCluskey, and J. Rossjohn. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6: 883-894. (Pubitemid 44851731)
39. Miles, J. J., D. C. Douek, and D. A. Price. 2011. Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol. Cell Biol. 89: 375-387.
40. Moss, P. A., R. J. Moots, W. M. Rosenberg, S. J. Rowland-Jones, H. C. Bodmer, A. J. McMichael, and J. I. Bell. 1991. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA 88: 8987-8990.
41. Lehner, P. J., E. C. Wang, P. A. Moss, S. Williams, K. Platt, S. M. Friedman, J. I. Bell, and L. K. Borysiewicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J. Exp. Med. 181: 79-91.
42. Trautmann, L., M. Rimbert, K. Echasserieau, X. Saulquin, B. Neveu, J. Dechanet, V. Cerundolo, and M. Bonneville. 2005. Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 175: 6123-6132. (Pubitemid 41508100)
43. Wilson, J. D., G. S. Ogg, R. L. Allen, P. J. Goulder, A. Kelleher, A. K. Sewell, C. A. O'Callaghan, S. L. Rowland-Jones, M. F. Callan, and A. J. McMichael. 1998. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188: 785-790. (Pubitemid 28387942)
44. Miles, J. J., D. Elhassen, N. A. Borg, S. L. Silins, F. E. Tynan, J. M. Burrows, A. W. Purcell, L. Kjer-Nielsen, J. Rossjohn, S. R. Burrows, and J. McCluskey. 2005. CTL recognition of a bulged viral peptide involves biased TCR selection. J. Immunol. 175: 3826-3834. (Pubitemid 41292043)
45. Price, D. A., J. M. Brenchley, L. E. Ruff, M. R. Betts, B. J. Hill, M. Roederer, R. A. Koup, S. A. Migueles, E. Gostick, L. Wooldridge, et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361. (Pubitemid 41668738)
46. Turner, S. J., and F. R. Carbone. 1998. A dominant V beta bias in the CTL response after HSV-1 infection is determined by peptide residues predicted to also interact with the TCR beta-chain CDR3. Mol. Immunol. 35: 307-316. (Pubitemid 28389691)
47. Maryanski, J. L., J. L. Casanova, K. Falk, H. Gournier, C. Jaulin, P. Kourilsky, F. A. Lemonnier, R. Lüthy, H. G. Rammensee, O. Rötzschke, et al. 1997. The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized. Hum. Immunol. 54: 117-128. (Pubitemid 27381021)
48. Ishizuka, J., G. B. Stewart-Jones, A. van der Merwe, J. I. Bell, A. J. McMichael, and E. Y. Jones. 2008. The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity 28: 171-182. (Pubitemid 351215238)
49. McHeyzer-Williams, M. G., and M. M. Davis. 1995. Antigen-specific development of primary and memory T cells in vivo. Science 268: 106-111.
50. McHeyzer-Williams, L. J., J. F. Panus, J. A. Mikszta, and M. G. McHeyzer-Williams. 1999. Evolution of antigen-specific T cell receptors in vivo: preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs. J. Exp. Med. 189: 1823-1838.
51. Fassò, M., N. Anandasabapathy, F. Crawford, J. Kappler, C. G. Fathman, and W. M. Ridgway. 2000. T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo. J. Exp. Med. 192: 1719-1730. (Pubitemid 32049765)
52. Caccamo, N., A. Barera, C. Di Sano, S. Meraviglia, J. Ivanyi, F. Hudecz, S. Bosze, F. Dieli, and A. Salerno. 2003. Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein. Clin. Exp. Immunol. 133: 260-266. (Pubitemid 36918601)
53. Sospedra, M., P. A. Muraro, I. Stefanová, Y. Zhao, K. Chung, Y. Li, M. Giulianotti, R. Simon, R. Mariuzza, C. Pinilla, and R. Martin. 2006. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J. Immunol. 176: 1951-1961. (Pubitemid 43134341)
54. Mycko, M. P., H.Waldner, D. E. Anderson, K. D. Bourcier, K. W. Wucherpfennig, V. K. Kuchroo, and D. A. Hafler. 2004. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules. J. Immunol. 173: 1689-1698. (Pubitemid 38971600)
55. Lang, H. L., H. Jacobsen, S. Ikemizu, C. Andersson, K. Harlos, L. Madsen, P. Hjorth, L. Sondergaard, A. Svejgaard, K. Wucherpfennig, et al. 2002. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 3: 940-943. (Pubitemid 35154007)
56. Doherty, D. G., J. E. Penzotti, D. M. Koelle, W. W. Kwok, T. P. Lybrand, S. Masewicz, and G. T. Nepom. 1998. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. J. Immunol. 161: 3527-3535.
57. Hennecke, J., and D. C. Wiley. 2002. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195: 571-581. (Pubitemid 34461502)
58. Starr, T. K., S. C. Jameson, and K. A. Hogquist. 2003. Positive and negative selection of T cells. Annu. Rev. Immunol. 21: 139-176. (Pubitemid 37174529)
59. Han, M., L. Harrison, P. Kehn, K. Stevenson, J. Currier, and M. A. Robinson. 1999. Invariant or highly conserved TCR alpha are expressed on double-negative (CD3+CD4-CD8-) and CD8+ T cells. J. Immunol. 163: 301-311. (Pubitemid 29295854)
60. Currier, J. R., H. Deulofeut, K. S. Barron, P. J. Kehn, and M. A. Robinson. 1996. Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum. Immunol. 48: 39-51. (Pubitemid 26238952)
61. Cibotti, R., J.-P. Cabaniols, C. Pannetier, C. Delarbre, I. Vergnon, J. M. Kanellopoulos, and P. Kourilsky. 1994. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180: 861-872.
62. Du Pasquier, R. A., M. J. Kuroda, J. E. Schmitz, Y. Zheng, K. Martin, F. W. Peyerl, M. Lifton, D. Gorgone, P. Autissier, N. L. Letvin, and I. J. Koralnik. 2003. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J. Virol. 77: 11918-11926. (Pubitemid 37339845)
63. Hegazy, A. N., M. Peine, C. Helmstetter, I. Panse, A. Fröhlich, A. Bergthaler, L. Flatz, D. D. Pinschewer, A. Radbruch, and M. Löhning. 2010. Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 32: 116-128.